Jaguar Health Inc.

13F holders, Q4 2024 (December 31)
12holders −1
2new positions
4sold out
$1.01avg. 13F price*

At the end of Q4 2024, 12 institutions reported holding Jaguar Health Inc. in their 13F filings, down 1 from Q3 2024. 2 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($98K), Vanguard Group Inc. ($60K) and UBS Group AG ($51K).

Company
Jaguar Health Inc.
CUSIP
47010C805
Latest filing quarter
Q4 2024

History

Number of 13F holders

051015 Q2 2024: 12Q2 2024Q3 2024: 13Q3 2024Q4 2024: 12Q4 2024

Total Exit/New Position Q3 2024 → Q4 2024

InstitutionsTotal Value
New Positions2$45K
Exits4$95K

All 13F filers, Q3 2024 → Q4 2024: 76,119 shares bought and 81,716 shares sold, net −5,597 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

Geode Capital Management, LLC 0.00% Add +18.2% 96,716 $98K
Vanguard Group Inc. 0.00% No change 59,503 $60K
UBS Group AG 0.00% Add +50.0% 50,657 $51K
HRT Financial LP 0.00% New 32,779 $33K
State Street Corp. 0.00% No change 15,127 $15K
Virtu Financial LLC 0.00% Reduce -46.3% 13,755 $14K
Susquehanna International Group, LLP 0.00% New 11,529 $12K
Morgan Stanley 0.00% No change 252 $255
BlackRock, Inc. 0.00% No change 110 $111
SBI Securities Co., Ltd. 0.00% — 103 $104
Bank of America Corp. 0.00% Add +28.0% 96 $97
Group One Trading LLC 0.00% No change 10 $10

"% of holder's portfolio" is JAGUAR HEALTH INC's weight in each manager's 13F, not the share of Jaguar Health Inc. the manager owns.